The IGF system in thyroid cancer: new concepts

New Concepts in Thyroid Disease

This volume is the publication of the proceedings of a conference held in Detroit, Michigan, in 1980. It is unfortunate that the publication was delayed nearly two years from the time of the meeting. However, knowledge is not accumulating quite as rapidly in this field as it is in some others, so the delay is not seriously deleterious. Over the past two decades knowledge of trace elements has i...

New Biomarkers for Cervical Cancer – Perspectives from the IGF System

MircoRNAs in thyroid cancer

Thyroid cancer, which is known as the most common type of endocrine cancer, has seen a growing prevalence in the last few years. On the other hand, only a small percentage of them are associated with malignancy and most of them are benign tumors. Therefore, the first step in the proper management of this type of cancer is to distinguish malignant tumors from benign ones, and today, we are tryin...

INSULINOMA NEW CONCEPTS IN MANAGEMENT

In this report, nine patients with insulinoma who were operated on between 19H5 and I <J<J3 at the Shohada Medical Center affiliated to the Shahid Beheshti University of Medical Sciences in Tehran are presented. There were three males and six females (male to female ratio I :2) and the patients' age ranged from 23 to 60 years old (mean age 37.6 years old). Duration of symptoms was from thr...

The IGF system and breast cancer.

The IGF system components have been implicated in breast cancer progression. IGF-I and IGF-II are mitogenic and anti-apoptotic peptides that influence the proliferation of various cell types including normal and transformed breast epithelial cells. The IGF system is a key growth regulatory pathway in breast cancer. As various components of the IGF system have been directly or indirectly implica...